Literature DB >> 15825234

Current concepts in screening for noncommunicable disease: World Health Organization Consultation Group Report on methodology of noncommunicable disease screening.

K Strong, N Wald, A Miller, A Alwan.   

Abstract

Screening people for serious diseases is receiving increasing attention as studies demonstrates the potential benefits of early detection and early intervention in preventing morbidity and mortality. Screening tests are available for some of the most important noncommunicable diseases, including cardiovascular disease, type 2 diabetes and several site-specific cancers. However, screening guidelines for cardiovascular disease, cancers and diabetes vary within and between countries because many national and international organizations are developing their own guidelines. There is a need to address the issue of screening for disease, with an emphasis on providing accurate and practical information relevant to all countries. This report arose from a Consultation Group meeting held at WHO headquarters in Geneva. It presents an examination of the principles of screening with an emphasis on noncommunicable disease prevention and control policy.

Entities:  

Mesh:

Year:  2005        PMID: 15825234     DOI: 10.1258/0969141053279086

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  28 in total

Review 1.  Design of cancer screening trials/randomized trials for evaluation of cancer screening.

Authors:  Anthony B Miller
Journal:  World J Surg       Date:  2006-07       Impact factor: 3.352

Review 2.  Informed choice for screening: implications for evaluation.

Authors:  Les Irwig; Kirsten McCaffery; Glenn Salkeld; Patrick Bossuyt
Journal:  BMJ       Date:  2006-05-13

Review 3.  Screening for lung cancer with low-dose computed tomography: a review of current status.

Authors:  Henry M Marshall; Rayleen V Bowman; Ian A Yang; Kwun M Fong; Christine D Berg
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

Review 4.  Type 1 diabetes: A predictable disease.

Authors:  Kimber M Simmons; Aaron W Michels
Journal:  World J Diabetes       Date:  2015-04-15

5.  Ethical issues in screening for hearing impairment in newborns in developing countries.

Authors:  B O Olusanya; L M Luxon; S L Wirz
Journal:  J Med Ethics       Date:  2006-10       Impact factor: 2.903

6.  Prevalence of Mycoplasma genitalium and Azithromycin-resistant Infections Among Remnant Clinical Specimens, Los Angeles.

Authors:  Lao-Tzu Allan-Blitz; Elisa Mokany; Shelley Campeau; Rachel Wee; Chelsea Shannon; Jeffrey D Klausner
Journal:  Sex Transm Dis       Date:  2018-09       Impact factor: 2.830

7.  Celiac disease diagnosis and management: a 46-year-old woman with anemia.

Authors:  Daniel Leffler
Journal:  JAMA       Date:  2011-10-12       Impact factor: 56.272

Review 8.  Colorectal cancer: from prevention to personalized medicine.

Authors:  Gemma Binefa; Francisco Rodríguez-Moranta; Alex Teule; Manuel Medina-Hayas
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

9.  Consolidated principles for screening based on a systematic review and consensus process.

Authors:  Mark J Dobrow; Victoria Hagens; Roger Chafe; Terrence Sullivan; Linda Rabeneck
Journal:  CMAJ       Date:  2018-04-09       Impact factor: 8.262

10.  Health screening for emerging non-communicable disease burdens among the global poor: Evidence from sub-Saharan Africa.

Authors:  Alberto Ciancio; Fabrice Kämpfen; Hans-Peter Kohler; Iliana V Kohler
Journal:  J Health Econ       Date:  2020-11-09       Impact factor: 3.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.